7
Stegeman, Raymond, Nijman, Maaike, Breur, Johannes M.P.J., Groenendaal, Floris, Haas, Felix, Derks, Jan B., Nijman, Joppe, van Beynum, Ingrid M., Taverne, Yannick J.H.J., Bogers, Ad J.J.C., Helbing, Willem A., de Boode, Willem P., Bos, Arend F., Berger, Rolf M.F., Accord, Ryan E., Roes, Kit C.B., de Wit, G. Ardine, Jansen, Nicolaas J.G., Benders, Manon J.N.L.
Veröffentlicht in: Stegeman , R , Nijman , M , on behalf of the CRUCIAL trial consortium , Breur , J M P J , Groenendaal , F , Haas , F , Derks , J B , Nijman , J , van Beynum , I M , Taverne , Y J H J , Bogers , A J J C , Helbing , W A , de Boode , W P , Bos , A F , Berger , R M F , Accord , R E , Roes , K C B , de Wit , G A , Jansen , N J G & Benders , M J N L 2022 , ' CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL) : study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial ' , Trials , vol. 23 , no. 1 , 174 . https://doi.org/10.1186/s13063-022-06098-y;
2022